KR900700136A - 특정 paf 길항제/항히스타민제 조성물 - Google Patents

특정 paf 길항제/항히스타민제 조성물

Info

Publication number
KR900700136A
KR900700136A KR1019890702438A KR890702438A KR900700136A KR 900700136 A KR900700136 A KR 900700136A KR 1019890702438 A KR1019890702438 A KR 1019890702438A KR 890702438 A KR890702438 A KR 890702438A KR 900700136 A KR900700136 A KR 900700136A
Authority
KR
South Korea
Prior art keywords
certain
paf antagonist
compositions
antihistamine
antihistamine compositions
Prior art date
Application number
KR1019890702438A
Other languages
English (en)
Other versions
KR930009786B1 (ko
Inventor
모타심 빌라 엠.
Original Assignee
쉐링 코포레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쉐링 코포레이션 filed Critical 쉐링 코포레이션
Publication of KR900700136A publication Critical patent/KR900700136A/ko
Application granted granted Critical
Publication of KR930009786B1 publication Critical patent/KR930009786B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
KR1019890702438A 1988-04-27 1989-04-24 특정 paf 길항제/항히스타민제 조성물 KR930009786B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18653588A 1988-04-27 1988-04-27
US186,535 1988-04-27
PCT/US1989/001671 WO1989010143A1 (en) 1988-04-27 1989-04-24 Certain paf antagonist antihistamine combinations and methods

Publications (2)

Publication Number Publication Date
KR900700136A true KR900700136A (ko) 1990-08-11
KR930009786B1 KR930009786B1 (ko) 1993-10-11

Family

ID=22685331

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890702438A KR930009786B1 (ko) 1988-04-27 1989-04-24 특정 paf 길항제/항히스타민제 조성물

Country Status (15)

Country Link
EP (2) EP0345931B1 (ko)
JP (1) JPH0655673B2 (ko)
KR (1) KR930009786B1 (ko)
AT (1) ATE84724T1 (ko)
AU (1) AU619555B2 (ko)
CA (1) CA1327316C (ko)
DE (1) DE68904475T2 (ko)
DK (1) DK255190A (ko)
ES (1) ES2044100T4 (ko)
IE (1) IE63697B1 (ko)
IL (1) IL90100A (ko)
MY (1) MY106956A (ko)
NZ (1) NZ228879A (ko)
WO (1) WO1989010143A1 (ko)
ZA (1) ZA893101B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
US6277846B1 (en) * 1990-05-31 2001-08-21 Allergan Sales, Inc. Use of platelet activating factor antagonists as anti-pruritic agents
DK0469477T3 (da) * 1990-08-02 1995-12-27 Hoffmann La Roche Antiallergisk kombination
US5227378A (en) * 1990-08-02 1993-07-13 Hoffmann-La Roche Inc. Combination of PAF antagonists and LTD4 antagonists for the treatment of allergic reactions
FR2673842B1 (fr) * 1991-03-13 1993-12-24 Rhone Poulenc Rorer Sa Nouvelles compositions liquides a base de derives de la piperidine substitues en 1,4.
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
JP3060287B2 (ja) * 1995-10-09 2000-07-10 参天製薬株式会社 アパファントを主薬とする水性点眼剤
DE10007203A1 (de) 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
US8492376B2 (en) * 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539332A (en) * 1983-11-14 1985-09-03 Merck & Co., Inc. 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
NZ211146A (en) * 1984-02-29 1987-10-30 Merck & Co Inc 2,5-diaryl-tetrahydrothiophene derivatives and pharmaceutical compositions
US4595693A (en) * 1984-06-04 1986-06-17 Merck & Co., Inc. Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as PAF-antagonists
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
US4910206A (en) * 1986-07-14 1990-03-20 Sandoz Pharmaceuticals Corp. 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

Also Published As

Publication number Publication date
WO1989010143A1 (en) 1989-11-02
ES2044100T4 (es) 1996-07-16
ATE84724T1 (de) 1993-02-15
NZ228879A (en) 1992-08-26
AU619555B2 (en) 1992-01-30
IL90100A0 (en) 1989-12-15
MY106956A (en) 1995-08-30
JPH03502097A (ja) 1991-05-16
DK255190D0 (da) 1990-10-23
EP0345931A1 (en) 1989-12-13
DE68904475D1 (de) 1993-03-04
DE68904475T2 (de) 1993-05-13
DK255190A (da) 1990-10-23
KR930009786B1 (ko) 1993-10-11
EP0345931B1 (en) 1993-01-20
IE891362L (en) 1989-10-27
JPH0655673B2 (ja) 1994-07-27
AU3578289A (en) 1989-11-24
ZA893101B (en) 1989-12-27
IL90100A (en) 1995-01-24
CA1327316C (en) 1994-03-01
EP0402422A1 (en) 1990-12-19
IE63697B1 (en) 1995-05-31
ES2044100T3 (es) 1994-01-01

Similar Documents

Publication Publication Date Title
DE3885816D1 (de) Mischungen von Polycarbonat und von Siloxan-Polyetherimid-Copolymer.
DE68920529T2 (de) Blockcopolymere und Zusammensetzungen davon.
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
DE3889091D1 (de) Härtbare Zusammensetzung von Oxyalkylenpolymeren.
ATE107130T1 (de) Zusammensetzung und ihre verwendung.
IE831613L (en) Heterocyclyl piperidine compounds
DE68922366T2 (de) Piperidinyl-Benzimidazole als Antihistaminica.
DE68910799T2 (de) Faserbehandlungszusammensetzung.
DE68906345T2 (de) Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten.
DE69116705T2 (de) Antiglancoma-Zusammensetzungen enthaltend 3-Arylcarbonyl-1-aminoalkyl-1H-indol
KR900700136A (ko) 특정 paf 길항제/항히스타민제 조성물
DE58902290D1 (de) Sauerstoffabsorptionsmittel und verwendung desselben.
DE3887345D1 (de) Fluoriertes copolymer und sperrschichten.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
DE69012882T2 (de) Herstellung von Stickstoffzusammensetzungen.
BR8904606A (pt) Composicao,produto endurecivel e aplicacao
DE3881991T2 (de) Zusammensetzung von Gleitgliedern.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DE68919593D1 (de) Verwendung von Zofenopril zur Herstellung von Medikamenten gegen rheumatoide Arthritis.
DE68910057D1 (de) Behandlungszusammensetzungen.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
DE3882545D1 (de) Verwendung von trifluormethansulfonamid gegen glaukom.
DE58902310D1 (de) Tetrahydropyridin-derivate.
NO165859C (no) Note-laeremiddel i form av spill.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19991005

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee